Not applicableStudy completedNCT01780857What this trial is testingImmune Signature of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Baylor Research Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07013201What this trial is testingA 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis LEO Pharma 135
Not applicableStudy completedNCT04459507What this trial is testingA Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanWho this might be right forPalmoplantar Pustulosis Janssen Pharmaceutical K.K. 276
Testing effectiveness (Phase 2)Study completedNCT03135548What this trial is testingInitial Dosing of BI 655130 in Palmoplantar Pustulosis PatientsWho this might be right forPsoriasis Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Study completedNCT03633396What this trial is testingEvaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Vanda Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT04451720What this trial is testingStudy of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) AbbVie 119
Early research (Phase 1)Study completedNCT03972280What this trial is testingSafety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar PustulosisWho this might be right forHidradenitis SuppurativaPalmoplantar Pustulosis CSL Behring 39
Testing effectiveness (Phase 2)Study completedNCT04015518What this trial is testingTest How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT03988335What this trial is testingEvaluate RIST4721 in Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Aristea Therapeutics, Inc. 35
Not applicableNot Yet RecruitingNCT07000630What this trial is testingEfficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Peking University First Hospital 25
Large-scale testing (Phase 3)Looking for participantsNCT07219420What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis UCB Biopharma SRL 300
Testing effectiveness (Phase 2)Study completedNCT01845987What this trial is testingThe Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar PustulosisWho this might be right forPalmoplantaris Pustulosis Janssen Pharmaceutical K.K. 49
Large-scale testing (Phase 3)Study completedNCT05174065What this trial is testingPhase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Amgen 176
Testing effectiveness (Phase 2)Study completedNCT00301002What this trial is testingStudy to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar PustulosisWho this might be right forPsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more The Guenther Dermatology Research Centre 15
Large-scale testing (Phase 3)Study completedNCT00353119What this trial is testingA Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar PustulosisWho this might be right forPalmoplantaris Pustulosis Innovaderm Research Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT04493424What this trial is testingTest Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With SpesolimabWho this might be right forPalmoplantar Pustulosis Boehringer Ingelheim 108
Not applicableLooking for participantsNCT05994976What this trial is testingCollection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersWho this might be right forAcneAtopic DermatitisChronic Hand Eczema+3 more Innovaderm Research Inc. 500
Not applicableLooking for participantsNCT07270003What this trial is testingA Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Xijing Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT05710185What this trial is testingDeucravacitinib for the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Brigham and Women's Hospital 3
Testing effectiveness (Phase 2)Ended earlyNCT05194839What this trial is testingA Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Aristea Therapeutics, Inc. 79